The DOI matches its Crossref record, with a small difference in title or year; 263 of the 263 references it cites were found in a registry or an index.
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Open accessAbstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As such, while all patients with T2DM and CAD certainly benefit from a blood pressure of <140/90 mm Hg,5,63–66,76”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people who already have diabetes, lifestyle modification and pharmacological treatment, as well as blood pressure and cholesterol control, can delay progression to complications and reduce mortality, or even help with remission, especially if started early.1,2,58–62”
From Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredIn the citing paper
“Epidemiological studies have shown that high levels of LDL-C and non-HDL-C and low levels of HDL-C are associated with an increased risk of CV events and mortality in patients with and without diabetes.246”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [246]
In the citing paper
“The most common causes of death in patients with T2DM and CKD are atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) (6,7).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [7]
In the citing paper
“The presence of hypertension in patients with T2DM significantly increases the risk of myocardial infarction, stroke, and all-cause mortality.63,64”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“The prevalence of hypertension in patients with T2DM is ≈2-fold greater than in the general population, with the vast majority of patients with T2DM (70%–80%) having concomitant hypertension.63”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Early interventional randomized trials showed benefit of aggressive blood pressure reduction in reducing the increased risk of both macrovascular and microvascular events in patients with T2DM.63”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Epidemiological observations have demonstrated that there is a progressive increase in the risk of macrovascular and microvascular events with increasing levels of systolic blood pressure starting at 115 mm Hg.63–65”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Instead, evidence to support lifestyle and health behavior management for T2DM and stable CAD has been extrapolated from primary prevention trials and from subgroups of participants with T2DM from studies focusing on the secondary prevention of CAD.63,136”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
RetractedToprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Research works printed but not linked: 2
- 10.1161/circ.100.10.1132 · DOI
- Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, de Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, Levey AS, Riella MC, Shlipak MG, Wang H, White CT, Winearls CG. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Cited by
Sorted by citations
Items 101–200 of 386
Christiansen, M., Grove, E. L., & Hvas, A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1726096 · Cited by 28
Asbaghi, O., Ashtary‐Larky, D., Mousa, A., Kelishadi, M. R., & Moosavian, S. P. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab121 · Cited by 31
Selig, J. I., Ouwens, D. M., Raschke, S., Thoresen, G. H., Fischer, J. W., Lichtenberg, A., Akhyari, P., & Barth, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.019 · Cited by 27
Glurich, I., Nycz, G. R., & Acharya, A. (2017) · Clinical Medicine & Research · doi:10.3121/cmr.2017.1348 · Cited by 29
Hof, J. V., Duval, S., Walts, A., Kopecky, S. L., Luepker, R. V., & Hirsch, A. T. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006328 · Cited by 26
Wang, X., Wang, Z., Liu, D., Jiang, H., Cai, C., Li, G., & Yu, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.839640 · Cited by 27
Kilonzo, S. B., Gunda, D. W., Bakshi, F. A., Kalokola, F., Mayala, H. A., & Dadi, H. K. (2017) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v27i5.5 · Cited by 27
Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease
Yang, G., Li, Y.-Z., Cui, L., Jiang, H., Li, X., Jin, C., Jin, D., Zhao, G., Jin, J., Sun, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163027 · Cited by 25
The role of Krüppel-like factor 14 in the pathogenesis of atherosclerosis
Xie, W., Li, L., Zheng, X., Yin, W., & Tang, C. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.011 · Cited by 25
Komici, K., Femminella, G. D., de Lucia, C., Cannavò, A., Bencivenga, L., Corbi, G., Leosco, D., Ferrara, N., & Rengo, G. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-0973-2 · Cited by 27
Virstyuk, N. G., & Ikwuka, A. O. (2017) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-319-70548-4_582 · Cited by 32
Aspirin for the primary prevention of cardiovascular disease: latest evidence
Capodanno, D., Ingala, S., Calderone, D., & Angiolillo, D. J. (2019) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1651199 · Cited by 24
Cardioprotective diabetes drugs: what cardiologists need to know
Brown, J. M., & Everett, B. M. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000181 · Cited by 23
Prevalence and predictors of stroke among individuals with prediabetes and diabetes in Florida
Khan, M. M., Roberson, S. L., Reid, K. M., Jordan, M., & Odoi, A. (2022) · BMC Public Health · doi:10.1186/s12889-022-12666-3 · Cited by 23
Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice
Yuan, C., Hu, J., Parathath, S., Grauer, L., Blachford, C., Bagdasarov, S., Goldberg, I. J., Ramasamy, R., & Fisher, E. A. A. (2018) · Diabetes · doi:10.2337/db18-0156 · Cited by 24
Patoulias, D., Stavropoulos, K., Imprialos, K. P., Katsimardou, A., Kalogirou, M., Koutsampasopoulos, K., Zografou, I., Papadopoulos, C. E., Karagiannis, A. I., & Doumas, M. N. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107927 · Cited by 24
Prevention of Child Sexual Abuse by Targeting Pre-Offenders Before First Offense
Levine, J. A., & Dandamudi, K. (2016) · Journal of Child Sexual Abuse · doi:10.1080/10538712.2016.1208703 · Cited by 24
Deseive, S., Straub, R., Kupke, M., Broersen, A., Kitslaar, P., Stocker, T., Massberg, S., Hadamitzky, M., & Hausleiter, J. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2018.09.008 · Cited by 24
Kang, E. Y., Lin, Y.-H., Wang, N., Yeung, L., Luo, C., Wu, W.-C., Sun, C., Kang, J., Hung, M., & Chen, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025455 · Cited by 23
Risk Factors for Cardiovascular Disease
Kucia, A. M., & Hartley, A. (2022) · Wiley eBooks · doi:10.1002/9781119117810.ch5 · Cited by 26
Mayr, H. L., Kostjasyn, S., Campbell, K. L., PALMER, M. A., & Hickman, I. J. (2020) · Nutrients · doi:10.3390/nu12113395 · Cited by 23
SUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes
Mao, F., Liu, S., Qiao, X., Zheng, H., Xiong, Q., Wen, J., Zhang, S., Zhang, Z., Ye, H., Shi, H., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4689 · Cited by 22
Sugawara, M., Gotō, Y., Yamazaki, T., Teramoto, T., Oikawa, S., Shimada, K., Uchiyama, S., Ando, K., Ishizuka, N., Murata, M., et al. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0313-0 · Cited by 22
Personal Glucose Meter for α-Glucosidase Inhibitor Screening Based on the Hydrolysis of Maltose
Tian, T., Chen, G.-Y., Zhang, H., & Yang, F.-Q. (2021) · Molecules · doi:10.3390/molecules26154638 · Cited by 22
Mayr, H. L., Kelly, J. T., Macdonald, G. A., Russell, A. W., & Hickman, I. J. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.01.012 · Cited by 26
Downs, S., & Fanzo, J. (2015) · Current Nutrition Reports · doi:10.1007/s13668-015-0142-6 · Cited by 23
Individualised treatment targets in patients with type-2 diabetes and hypertension
for the DIALOGUE study group, Schmieder, R. E., Tschöpe, D., Koch, C., Ouarrak, T., & Gitt, A. K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0661-8 · Cited by 21
Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
Hinnen, D. A., & Kruger, D. F. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s188705 · Cited by 23
Caldeira, D., Alves, M., David, C., Costa, J. N., Ferreira, J. J., & Pinto, F. J. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.11.004 · Cited by 21
Ng, M., Zhou, W., Vardhanabhuti, V., Lee, C., Yu, E. Y. T., Wan, E. Y. F., Chan, K., Yan, A. T.-K., Ip, T., Yiu, K., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01019-2 · Cited by 21
Liu, Z., Tang, J., Cheng, M.-D., Jiang, L.-Z., Guo, Q., Zhang, J., Zhang, Z.-L., Song, F.-H., Wang, K., Fan, L., et al. (2021) · Coronary Artery Disease · doi:10.1097/mca.0000000000001021 · Cited by 20
Assessing Cardiovascular Risk and Testing in Type 2 Diabetes
Saeed, A., & Ballantyne, C. M. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0831-4 · Cited by 20
Park, M. S., Oh, H., & You, S. (2020) · Library & Information Science Research · doi:10.1016/j.lisr.2020.101030 · Cited by 22
Feng, W., Li, Z., Guo, W., Fan, X., Zhou, F., Zhang, K., Ou, C., Huang, F., & Chen, M. (2020) · Diabetes Care · doi:10.2337/dc20-0838 · Cited by 19
Chen, K.-C., Yin, W. H., Wu, C., Chan, S. H., Wu, Y., Wang, K. Y., Chang, K.-C., Hwang, J., Voon, W., Hsieh, C., et al. (2018) · Europe PMC (PubMed Central) · doi:10.6515/acs.201805_34(3).20180207b · Cited by 19
DEEDWANIA, P. C., Acharya, T., Kotak, K., Fonarow, G. C., Cannon, C. P., Laskey, W. K., Peacock, W. F., Pan, W., & Bhatt, D. L. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.02.025 · Cited by 20
Self-citationGeneralizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus
Berkowitz, S. A., Sussman, J. B., Jonas, D. E., & Basu, S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.012 · Cited by 19
Ziaee, R. S., Keshani, P., Salehi, M., & Ghaem, H. (2021) · Advances in Preventive Medicine · doi:10.1155/2021/2934082 · Cited by 19
Vurusaner, B., Thevkar-Nages, P., Kaur, R., Giannarelli, C., Garabedian, M. J., & Fisher, E. A. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15349-6 · Cited by 18
Diabetes and Cardiovascular Disease
Sidhu, M. S., & Farkouh, M. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47870-0.00043-x · Cited by 17
Hemoglobin A1c levels and risk of sudden cardiac death: A nested case-control study
Patel, R. B., Moorthy, M. V., Chiuve, S. E., Pradhan, A. D., Cook, N. R., & Albert, C. M. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.08.044 · Cited by 18
Dion, F., Dumayne, C., Henley, N., Beauchemin, S., Arias, E. B., Leblond, F. A., Lesage, S., Lefrançois, S., Cartee, G. D., & Pichette, V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176650 · Cited by 18
Giustino, G., Redfors, B., Mehran, R., Kirtane, A. J., Baber, U., Généreux, P., Witzenbichler, B., Neumann, F., Weisz, G., Maehara, A., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.091 · Cited by 18
Weidmann, L., Obeid, S. N., Mach, F., Shahin, M., Yousif, N., Denegri, A., Müller, O., Räber, L., Matter, C. M., & Lüscher, T. F. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.050 · Cited by 18
Pourkeramati, A., Mehrjardi, E. Z., Tezerjani, M. D., & Seifati, S. M. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s252552 · Cited by 18
Valensi, P. E., Henry, P., Boccara, F., Cosson, E., Prévost, G., Emmerich, J., Ernande, L., Marcadet, D. M., Mousseaux, É., Rouzet, F., et al. (2020) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2020.07.003 · Cited by 19
Role of circulating factors in cardiac aging
Cannata, A. N., Marcon, G., Cimmino, G., Camparini, L., Ciucci, G., Sinagra, G., & Loffredo, F. S. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.95 · Cited by 20
Comparative risk of new‐onset diabetes mellitus for antihypertensive drugs: A network meta‐analysis
Li, Z., Li, Y., Liu, Y., Xu, W., & Wang, Q. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13108 · Cited by 17
Ten things to know about ten cardiovascular disease risk factors (“ASPC Top Ten – 2020”)
Bays, H. E. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100003 · Cited by 18
Morimoto, T., Sakuma, I., Sakuma, M., Tokushige, A., Natsuaki, M., Asahi, T., Shimabukuro, M., Nomiyama, T., Arasaki, O., Node, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44885-x · Cited by 16
Akhabue, E., Rittner, S. S., Carroll, J. E., Crawford, P. M., Dant, L., Laws, R., Leo, M. C., Puro, J. E., & Persell, S. D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005627 · Cited by 16
Tailakh, M. A., Ishay, S. Y., Awesat, J., Poupko, L., Sahar, G., & Novack, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122739 · Cited by 16
Zhao, B., Wu, Q., Wang, L., Liao, C., Dong, Y., Xu, J., Wei, Y., & Zhang, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592116 · Cited by 15
Boussageon, R., Blanchard, C., Charuel, É., Ménini, T., Pereira, B., Naudet, F., Kassaï, B., Gueyffier, F., Cucherat, M., & Vaillant-Roussel, H. (2022) · Therapies · doi:10.1016/j.therap.2022.10.008 · Cited by 15
The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with Diabetes
Ziaeian, B., Dinkler, J., Guo, Y., & Watson, K. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0703-5 · Cited by 15
Managing dyslipidaemia in type 2 diabetes mellitus
Szalat, A., Durst, R. Y., & Leitersdorf, E. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.05.004 · Cited by 17
Terleira‐Fernández, A. I., Lecumberri, R., Suárez‐Gea, M. L., Calvo, G., Vargas, E., & Gómez‐Outes, A. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1642644 · Cited by 17
Albenque, G., Ruşinaru, D., Bellaiche, M., Lena, C. D., Gabrion, P., Delpierre, Q., Malaquin, D., Tribouilloy, C. M., & Bohbot, Y. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.10.013 · Cited by 15
Raebel, M. A., Dyer, W., Nichols, G. A., Goodrich, G. K., & Schmittdiel, J. A. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1994 · Cited by 15
Novel Biomarkers for Predicting Cardiovascular Disease in Patients With Diabetes
Retnakaran, R. R. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.10.017 · Cited by 15
Managing dyslipidemia for CVD prevention
Ciffone, N. A., & COPPLE, T. M. (2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000550246.96902.de · Cited by 15
Jalilian, H., Javanshir, E., Torkzadeh, L., Fehresti, S., Mir, H., Heidarijamebozorgi, M., & Heydari, S. (2023) · Health Science Reports · doi:10.1002/hsr2.1096 · Cited by 15
Neeland, I. J., & Patel, K. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54835-9.00004-1 · Cited by 14
Zehirlioğlu, L., & Mert, H. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.06.006 · Cited by 15
Koh, S. M., Chung, S. H., Yum, Y., Park, S.-J., Joo, H. J., Kim, Y., & Kim, E. J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01681-8 · Cited by 15
Cheng, Y., Wang, D., Yang, Y., Miao, Y., Shen, W., Tian, J., & Sheng, C. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110831 · Cited by 14
Zalke, J. B., Narkhede, N. P., Pandhurnekar, C. P., Rotake, D. R., & Singh, S. G. (2023) · Nanotechnology · doi:10.1088/1361-6528/ad090c · Cited by 13
Blood pressure targets for hypertension in patients with type 2 diabetes
Aronow, W. S., & Shamliyan, T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.36 · Cited by 15
Association of physical activity and trajectories of physical activity with cardiovascular disease
Chrysant, S. G., & Chrysant, G. S. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2174102 · Cited by 13
Sepúlveda, C., Palomo, I. F., & Eduardo Fuentes, Q. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.03.004 · Cited by 14
Vazifehkhorani, A. K., Karimzadeh, M., Poursadeghiyan, M., & Rahmati-Najarkolaei, F. (2018) · Iranian Rehabilitation Journal · doi:10.32598/irj.16.4.395 · Cited by 13
Clinical Implications of Single-Cell Microfluidic Devices for Hematological Disorders
Hansen, C. E., & Lam, W. A. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01013 · Cited by 13
Kaya, D. G., Arslan, N., Ayyıldız, F., Bayramoğlu, E., Turan, H., & Ercan, O. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01593-6 · Cited by 12
Tanaka, A., Yoshida, H., Nanasato, M., Oyama, J., Ishizu, T., Ajioka, M., Ishiki, R., Saito, M., Shibata, Y., Kaku, K., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.055 · Cited by 12
Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice
Asai, A., Shuto, Y., Nagao, M., Kawahara, M., Miyazawa, T., Sugihara, H., & Oikawa, S. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48223 · Cited by 12
Acampa, W., Assante, R., Zampella, E., Petretta, M., & Cuocolo, A. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01846-1 · Cited by 12
Nuamchit, T., Siriwittayawan, D., & Thitiwuthikiat, P. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s265157 · Cited by 12
Bedane, D. A., Tadesse, S., Gare, M. B., Demissie, W. R., & Desu, G. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02110-6 · Cited by 12
Alfuhied, A., Gulsin, G. S., Athithan, L., Brady, E. M., Parke, K. S., Henson, J. J., Redman, E. L., Marsh, A.-M., Yates, T. E., Davies, M. J., et al. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02578-z · Cited by 12
Ghamri, R. A., Alzahrani, N. S., Alharthi, A. M., Gadah, H. J., Badoghaish, B. G., & Alzahrani, A. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1261-6 · Cited by 12
Liu, T., Cui, L.-J., Xue, H., Zhi, L., Yang, X.-H., Yang, H., Liu, M.-M., Bai, T., Liu, Z.-H., Zhang, M., et al. (2020) · bioRxiv · doi:10.3389/fphar.2021.739637 · Cited by 18
Designing Tough Hydrogel Shells for Glucose Sensing
Ko, Y., Oh, Y., Park, C. H., & Kim, S. (2024) · Small · doi:10.1002/smll.202310283 · Cited by 11
Kianoush, S., Rifai, M. A., Whelton, S. P., Shaya, G. E., Bush, A. L., Graham, G. N., Wong, N. D., & Blaha, M. J. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.021 · Cited by 11
Su, S., Liao, Y., & Wu, M. (2018) · Heart & Lung · doi:10.1016/j.hrtlng.2018.07.001 · Cited by 11
Mamudu, H. M., Alamian, A., Paul, T. K., Subedi, P., Wang, L., Jones, A., Alamin, A. E., Stewart, D. W., Blackwell, G. G., & Budoff, M. J. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118791654 · Cited by 11
Liu, Q., Hua, B., Su, W., Di, B., Yu, S., Gao, S., Liu, H., Zhao, X.-Q., Li, W., & Li, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109527 · Cited by 11
White, N. D., Lenz, T. L., Skrabal, M. Z., Skradski, J. J., & Lipari, L. (2018) · Europe PMC (PubMed Central) · Cited by 11
Agvall, B., Jonasson, J. M., Galozy, A., & Halling, A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02211-4 · Cited by 10
Duc, L. A., Tùng, N. T., Tran, O. T., Tri, N. Q., & Linh, N. T. (2023) · Mobile Networks and Applications · doi:10.1007/s11036-023-02184-w · Cited by 11
Berezin, A. Е. (2016) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000217 · Cited by 10
Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus
Bayomy, O. F., Rao, A. D., Garg, R., Vaidya, A., Kotin, A. R., Reiber, B. M. M., Nijmeijer, S. C. M., Carli, M. F. D., Jerosch‐Herold, M., Kwong, R. Y. K., et al. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0031 · Cited by 10
Baksh, S. N., Segal, J. B., McAdams‐DeMarco, M., Kalyani, R. R., Alexander, G. C., & Ehrhardt, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240141 · Cited by 10
Lin, H., Wu, Y., Wu, J., Chen, Q., Yu, J., & Lin, Y. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s341148 · Cited by 10
Rodríguez‐Gutiérrez, R., García-Leal, M., Raygoza-Cortez, K., Flores-Rodríguez, A., Moreno-Alvarado, M., Heredia-Martínez, E. M., Vazquez-Baquerizo, B., Guerra-Espiricueta, R., Muñoz-Silva, V., & González‐González, J. G. (2023) · Endocrine · doi:10.1007/s12020-023-03401-y · Cited by 11
Ballotari, P., Venturelli, F., Manicardi, V., Ferrari, F., Vicentini, M., Greci, M., Pignatti, F., Storani, S., & Rossi, P. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194784 · Cited by 10
Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence
Al‐Sofiani, M. E., Derenbecker, R., Quartuccio, M., & Kalyani, R. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1206-6 · Cited by 10
Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.
Rehni, A. K., & Dave, K. R. (2018) · PubMed · Cited by 10
Ramprasath, T., Freddy, A. J., Velmurugan, G., Tomar, D., Balakrishnan, R., Suvekbala, V., & Ramasamy, S. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200130094512 · Cited by 10
Yuan, D., Zhang, C., Jia, S., Jiang, L., Xu, L., Zhang, Y., Xu, J., Xu, B., Hui, R., Gao, R., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13361 · Cited by 10
Feingold, K. R. (2020) · Europe PMC (PubMed Central) · Cited by 10
Metadata
- Authors
- Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., Inzucchi, S. E., Kosiborod, M., Nelson, R. G., Patel, M. J., Pignone, M., Quinn, L., Schauer, P. R., Selvin, E., & Vafiadis, D. K.
- Affiliations
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- University of California San Diego (US)
- Pennington Biomedical Research Center (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Office of Dietary Supplements (US)
- National Institutes of Health (US)
- Yale University (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Illinois Chicago (US)
- Cleveland Clinic (US)
- American Heart Association (US)
- ORCID
- Venue
- Circulation
- Published
- 2015-08-25
- Volume
- 132
- Issue
- 8
- Pages
- 691-718
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC9728095
- OpenAlex
- W2172043580
- Cited by
- 386
- References
- 262
- Citations by year
- 2026: 16 · 2025: 8 · 2024: 18 · 2023: 18 · 2022: 35 · 2021: 40 · 2020: 45 · 2019: 41 · 2018: 55 · 2017: 61 · 2016: 42 · 2015: 7
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (ZIADK069062, P30DK079637)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- type 2 diabetes, cardiovascular disease prevention, primary prevention, blood pressure control, glycemic control, cholesterol management, aspirin therapy, lifestyle modification, kidney disease screening, subclinical cardiovascular disease, clinical guidelines
- MeSH terms
- American Heart Association, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Primary Prevention, Risk Factors, United States, Randomized Controlled Trials as Topic, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
